PMID- 31331188 OWN - NLM STAT- MEDLINE DCOM- 20200106 LR - 20200225 IS - 1526-2359 (Electronic) IS - 1073-2748 (Print) IS - 1073-2748 (Linking) VI - 26 IP - 1 DP - 2019 Jan-Dec TI - Projecting Cancer Incidence for 2025 in the 2 Largest Populated Cities in Vietnam. PG - 1073274819865274 LID - 10.1177/1073274819865274 [doi] LID - 1073274819865274 AB - The population size and projected demographics of Vietnam's 2 largest cities, Ho Chi Minh City (HCMC) and Hanoi, will change dramatically over the next decade. Demographic changes in an aging population coupled with income growth and changes in lifestyle will result in a very different distribution of common cancers in the future. The study aimed to project the number of cancer incidence in the 2 largest populated cities in Vietnam for the year 2025. Cancer incidence data from 2004 to 2013 collected from population-based cancer registries in these 2 cities were provided by Vietnam National Cancer Institute. Incidence cases in 2013 and the previous decades average annual percent changes of age-standardized cancer incidence rates combined with expected population growth were modeled to project cancer incidence for each cancer site by gender to 2025. A substantial double in cancer incidence from 2013 to 2025 resulted from a growing and aging population in HCMC and Hanoi. Lung, colorectum, breast, thyroid, and liver cancers, which represent 67% of the overall cancer burden, are projected to become the leading cancer diagnoses by 2025 regardless of genders. For men, the leading cancer sites in 2025 are predicted to be lung, colorectum, esophagus, liver, and pharynx cancer, and among women, they are expected to be breast, thyroid, colorectum, lung, and cervical cancer. We projected an epidemiological transition from infectious-associated cancers to a high burden of cancers that have mainly been attributed to lifestyle in both cities. We predicted that with 16.9% growth in the overall population and dramatic aging with these 2 urban centers, the burdens of cancer incidence will increase sharply in both cities over the next decades. Data on projections of cancer incidence in both cities provide useful insights for directing appropriate policies and cancer control programs in Vietnam. FAU - Nguyen, Sang Minh AU - Nguyen SM AD - 1 Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. FAU - Deppen, Stephen AU - Deppen S AD - 2 Geriatric Research Education and Clinical Center, Tennessee Valley Healthcare System, Nashville, TN, USA. AD - 3 Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. FAU - Nguyen, Giang Huong AU - Nguyen GH AD - 4 National Cancer Hospital, Hanoi, Vietnam. FAU - Pham, Dung Xuan AU - Pham DX AD - 5 Ho Chi Minh City Oncological Hospital, Ho Chi Minh City, Vietnam. FAU - Bui, Tung Duc AU - Bui TD AD - 6 Ho Chi Minh Cancer Registry, Ho Chi Minh City Oncological Hospital, Ho Chi Minh City, Vietnam. FAU - Tran, Thuan Van AU - Tran TV AD - 5 Ho Chi Minh City Oncological Hospital, Ho Chi Minh City, Vietnam. AD - 7 Vietnam National Cancer Institute, Hanoi, Vietnam. LA - eng GR - P20 CA210300/CA/NCI NIH HHS/United States PT - Journal Article PL - United States TA - Cancer Control JT - Cancer control : journal of the Moffitt Cancer Center JID - 9438457 SB - IM MH - Adolescent MH - Adult MH - Age Distribution MH - Aged MH - Aged, 80 and over MH - Aging MH - Child MH - Child, Preschool MH - Cities/epidemiology/statistics & numerical data MH - Female MH - *Forecasting MH - Humans MH - Incidence MH - Infant MH - Infant, Newborn MH - Linear Models MH - Male MH - Middle Aged MH - Neoplasms/*epidemiology MH - Population Dynamics/*trends MH - Registries/statistics & numerical data MH - Risk Factors MH - Vietnam/epidemiology MH - Young Adult PMC - PMC6651684 OTO - NOTNLM OT - age-standardized cancer incidence rates OT - cancer incidence OT - demographic shifts OT - projections; average annual percent changes COIS- Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2019/07/25 06:00 MHDA- 2020/01/07 06:00 PMCR- 2019/07/23 CRDT- 2019/07/24 06:00 PHST- 2019/07/24 06:00 [entrez] PHST- 2019/07/25 06:00 [pubmed] PHST- 2020/01/07 06:00 [medline] PHST- 2019/07/23 00:00 [pmc-release] AID - 10.1177_1073274819865274 [pii] AID - 10.1177/1073274819865274 [doi] PST - ppublish SO - Cancer Control. 2019 Jan-Dec;26(1):1073274819865274. doi: 10.1177/1073274819865274.